WEBINAR: Normalization of organ-on-a-chip samples for mass spectrometry based proteomics and metabolomics via dansylation-based assay – 28 June 2023

cnb825 webinar promo v1 |
Learn more
cn-bio-organ-on-a-chip-logo cn-bio-organ-on-a-chip-logo cn-bio-organ-on-a-chip-logo cn-bio-organ-on-a-chip-logo
  • Products
    • Explore our solutions


      PhysioMimix® products enable you to recreate complex human biology and accurately predict human drug responses

      PhysioMimix OOC

      PhysioMimix OOC systems
      Learn more

      Consumables

      • Multi-chip plates
      • 3D validated cells
      • NASH-in-a-box
      Learn more

      Models

      • Single-organ models
      • Liver-on-a-chip model
      • Multi-organ models

      Support packages

      • PhysioMimix® support packages
  • Applications
    • Discover the applications


      Investigate the application areas that our PhysioMimix® products and services support

      Learn more

      Disease modeling

      • Non-Alcoholic Steatohepatitis
      • Hepatitis B
      • Oncology
      • COVID-19
      Learn more

      Safety toxicology

      • Drug-induced liver injury
      • Immune-mediated toxicities
      Learn more

      ADME

      • Drug absorption
      • Drug metabolism
      • Drug bioavailability
      Learn more
  • Services
    • Studies as a service


      Our team will work collaboratively with you to design a study around your research goals and generate actionable data within weeks

      Learn more
      NAFLD / NASH icons

      NAFLD / NASH

      Drug-induced liver injury icon

      Drug-induced liver injury

      icon adme |

      ADME

      Oncology icon

      Oncology

  • Resources
  • Company
    • About us


      Meet the team, explore our culture and discover what to expect when working with us

      CN Bio team photo
      About us

      Latest news

      • CN Bio appoints Dr. Samantha Macro as Chief Financial Officer

      • Immune-mediated DILI – Predicting the unpredictable!

      • CN Bio appoints Deepak Singh as Vice President of Sales and Marketing

      View all news

      Upcoming Events

      • ISSX DMDG 2023

      • MPS World Summit Berlin 2023

      View all events

      Join the team!

      View all jobs
  • Contact
  • Products
    • PhysioMimix® OOC Microphysiological Systems
    • Consumables
      • PhysioMimix® multi-chip plates
      • 3D validated cells
      • NASH-in-a-box
    • Organ-on-a-chip models
    • Support packages
  • Applications
    • Disease modeling
    • Safety toxicology
    • ADME
  • Services
    • Non-Alcoholic Steatohepatitis
    • Drug-Induced Liver Injury
    • ADME
  • Resources
  • Company
    • About us
    • Events
    • News
    • Careers
  • Contact
  • Skip to main content
  • Skip to footer
Chat live with an expert

A Breath of Fresh Air

May 25, 2022 by

Resource > Webinars >

A Breath of Fresh Air


Novel approaches to human lung disease modelling for accelerated drug discovery

Filed under: COVID 19 and Disease modeling

web s5e1 |

Video content if present

A Breath of Fresh Air

Novel approaches to human lung disease modelling for accelerated drug discovery


Watch this webinar to learn:

  • Learn how to create advanced in vitro human bronchial and alveolar models
  • Understand how to emulate human disease, using Chronic Obstructive Pulmonary Disease (COPD) and COVID-19 examples
  • Discover how lung-on-a-chip models can be monitored for inflammatory responses to foreign bodies
  • Establish how to rapidly and efficiently test the efficacy and safety of new therapeutics
  • Better equip your department to respond rapidly to emerging threats to public health

Professor Wojciech Chrzanowski, Faculty of Medicine and Health, University of Sydney. Accelerating the discovery of new therapeutics for the treatment of lung injuries using patho/physiology mimicking models.

With a surge in Covid-related lung dysfunction and an increase in acute lung injuries due to air pollution a new strategy to regenerate lungs is needed. The progress in the development of new therapeutics is hampered by the lack of reliable lung models that enable rapid, cost-effective and high throughput testing of therapeutics. Animal models are too expensive/slow; cell cultures are too simple.

Professor Chrzanowski will outline the development of advanced human mimicking lung models (aka lung-on-a-chip), which emulate both healthy (for safety studies) and diseased lungs (for therapeutics efficacy). Chrzanowski will discuss the applications of the lung models, their advantages and disadvantages, as well as present future directions of the work.

 

Dr Emily Richardson, Lead Scientist – Assay Development, CN Bio. The development of alveolar and bronchial human microphysiological systems for use in respiratory infection research and therapeutics evaluation.

The Covid-19 pandemic has highlighted a need for more physiologically relevant human models that enable us to quickly identify treatments for emerging threats to public health.

Dr Richardson will share the development of two novel primary human lung-on-a-chip models, cultured using the PhysioMimix® OOC microphysiological system in an open well Transwell® air-liquid-interface. These distinct bronchial and alveolar in vitro models can be used for a precise understanding of Covid-19 biology and evaluation of therapeutics.


View our Q&A document from the live event.


Speaker Information:

Professor Wojciech Chrzanowski

Faculty of Medcine and Health
University of Sydney

emilyDr Emily Richardson

Lead Scientist
CN Bio

Video content if present

Speak to our experts

Speak directly with one of our OOC experts to see how our products and services can support your studies

Request a meeting

Footer

CN Bio logo

332 Cambridge Science Park, Milton Road
Cambridge, CB4 0WN

UK: +44 (0) 1223 737 941

US: +1 415 523 4005

Privacy | Cookies | Terms | Regulatory | Accessibility | Recycling

©2023 CN Bio Innovations Ltd
Registered No. ‍06517359. VAT No. GB978184563

Latest news

  • CN Bio appoints Dr. Samantha Macro as Chief Financial Officer June 6, 2023
  • Immune-mediated DILI – Predicting the unpredictable! March 16, 2023
  • CN Bio appoints Deepak Singh as Vice President of Sales and Marketing March 14, 2023

Upcoming events

ISSX DMDG 2023 June 11-14, 2023

MPS World Summit Berlin 2023 June 26-30, 2023